Nkarta, Inc.(NKTX)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | HASTINGS PAUL J Chief Executive Officer | Sale | -26,046 | -6.26%390,023 | $2.07 | $53,915 | View SEC filing | |
| 2026-01-20 | Mahmood Nadir President | Sale | -5,649 | -3.26%167,727 | $2.07 | $11,693 | View SEC filing | |
| 2025-06-20 | HASTINGS PAUL J Chief Executive Officer | Sale | -1,790 | -0.56%320,069 | $1.79 | $3,204 | View SEC filing | |
| 2025-01-17 | Shook David See Remarks | Sale | -8,638 | -4.33%190,955 | $2.20 | $19,004 | View SEC filing | |
| 2025-01-17 | Levin Alyssa See Remarks | Sale | -5,838 | -5.38%102,662 | $2.20 | $12,844 | View SEC filing | |
| 2025-01-17 | Brandenberger Ralph Chief Technical Officer | Sale | -7,447 | -5.63%124,796 | $2.20 | $16,383 | View SEC filing | |
| 2025-01-17 | HASTINGS PAUL J Chief Executive Officer | Sale | -17,378 | -5.15%319,859 | $2.20 | $38,232 | View SEC filing | |
| 2025-01-17 | Hager Alicia J. Chief Legal Officer | Sale | -9,584 | -6.13%146,735 | $2.20 | $21,085 | View SEC filing | |
| 2024-07-18 | Hager Alicia J. Chief Legal Officer | Sale | -3,396 | -3.17%103,819 | $8.00 | $27,168 | View SEC filing | |
| 2024-06-20 | Trager James Chief Scientific Officer | Sale | -456 | -0.30%150,959 | $5.60 | $2,554 | View SEC filing | |
| 2024-06-20 | HASTINGS PAUL J Chief Executive Officer | Sale | -1,770 | -0.73%240,737 | $5.60 | $9,912 | View SEC filing | |
| 2024-06-20 | Shook David Chief Medical Officer | Sale | -456 | -0.39%116,524 | $5.60 | $2,554 | View SEC filing | |
| 2024-06-20 | Hager Alicia J. Chief Legal Officer | Sale | -727 | -0.67%107,215 | $5.60 | $4,071 | View SEC filing | |
| 2024-06-20 | Brandenberger Ralph Chief Technical Officer | Sale | -229 | -0.29%79,743 | $5.60 | $1,282 | View SEC filing | |
| 2024-03-29 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +6,000,031 | +85.10%13,050,849 | $10.00 | $60,000,010 | View SEC filing | |
| 2024-03-28 | George Simeon Director | Purchase | +2,000,000 | +100.00%2,000,000 | $10.00 | $20,000,000 | View SEC filing | |
| 2024-03-05 | Brandenberger Ralph Chief Technical Officer | Sale | -8,367 | -9.47%79,972 | $12.51 | $104,671 | View SEC filing | |
| 2024-02-14 | Trager James Chief Scientific Officer | Sale | -4,143 | -2.70%149,415 | $12.00 | $49,716 | View SEC filing | |
| 2024-01-18 | Shook David Chief Medical Officer | Sale | -3,552 | -3.00%114,980 | $8.74 | $31,044 | View SEC filing | |
| 2024-01-18 | Trager James Chief Scientific Officer | Sale | -4,560 | -2.88%153,558 | $8.74 | $39,854 | View SEC filing | |
| 2024-01-18 | Brandenberger Ralph Chief Technical Officer | Sale | -2,512 | -2.99%81,576 | $8.74 | $21,955 | View SEC filing | |
| 2024-01-18 | HASTINGS PAUL J Chief Executive Officer | Sale | -9,697 | -2.42%390,507 | $8.74 | $84,752 | View SEC filing | |
| 2024-01-18 | Hager Alicia J. Chief Legal Officer | Sale | -4,554 | -4.05%107,942 | $8.74 | $39,802 | View SEC filing | |
| 2023-08-23 | Shook David Chief Medical Officer | Sale | -1,331 | -2.15%60,532 | $1.83 | $2,436 | View SEC filing | |
| 2023-06-22 | Trager James Chief Scientific Officer | Sale | -439 | -0.44%100,118 | $4.85 | $2,129 | View SEC filing |
1-25 of 74